BioSenic SA
Develops therapies for autoimmune diseases, inflammation, and bone disorders.
BIOS | BR
Overview
Corporate Details
- ISIN(s):
- BE0970179827 (+1 more)
- LEI:
- 549300HFIIMTOP1DFR76
- Country:
- Belgium
- Address:
- RUE GRANBONPRÉ 11, 1435 MONT-ST-GUIBERT
- Website:
- http://www.biosenic.com/
Description
BioSenic SA is a biotechnology company focused on developing innovative treatments for autoimmune diseases, inflammatory conditions, and bone disorders. The company's core activities are centered on two main technology platforms: one based on arsenic trioxide (ATO) for its immunomodulatory properties, and another involving allogeneic cell therapy for tissue repair and regeneration. BioSenic's objective is to address significant unmet medical needs in the fields of regenerative and immune medicine by advancing its clinical assets through development.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2020-05-11 07:00 |
02_BOTHE_AGO_2020-06-10_Procuration_FR.pdf
|
French | PDF • 609.6 KB | ||
| 2020-05-11 07:00 |
01_BOTHE_AGO_2020-06-10_Convocation_FR_Final.pdf
|
French | PDF • 853.7 KB | ||
| 2020-05-11 07:00 |
08_BOTHE_AGO_2020-06-10_CVs directors.pdf
|
French | PDF • 457.2 KB | ||
| 2020-05-11 07:00 |
07_BOTHE_AGO_2020-06-10_Comptes Annuels 2019.PDF
|
French | PDF • 780.2 KB | ||
| 2020-05-11 07:00 |
10_BOTHE_AGO_2020-06-10_Warrant Plan-Template_EN.pdf
|
English | PDF • 667.0 KB | ||
| 2020-05-11 07:00 |
10_BOTHE_AGO_2020-06-10_Warrant Plan-Template_FR.pdf
|
French | PDF • 663.9 KB | ||
| 2020-05-11 07:00 |
09_BOTHE_AGO_2020-06-10_Warrant Plan 2020_EN.pdf
|
English | PDF • 651.9 KB | ||
| 2020-05-11 07:00 |
05_BOTHE_AGO_2020-06-10_Rapport de gestion du CA au 2019-12-31-12_20200428.pdf
|
French | PDF • 2.1 MB | ||
| 2020-05-11 07:00 |
03_BOTHE_AGM_2020-06-10_Information shareholders rights_EN.pdf
|
English | PDF • 417.8 KB | ||
| 2020-05-11 07:00 |
09_BOTHE_AGO_2020-06-10_Warrant Plan 2020_FR.pdf
|
French | PDF • 663.7 KB | ||
| 2020-05-11 07:00 |
02_BOTHE_AGM_2020-06-10_Proxy form_EN.pdf
|
English | PDF • 662.3 KB | ||
| 2020-05-11 07:00 |
06_BOTHE_AGO_2020-06-10_Auditor Report_2019-12-31.pdf
|
French | PDF • 82.1 KB | ||
| 2020-05-11 07:00 |
01_BOTHE_AGM_2020-06-10_Convening notice_EN_Final.pdf
|
English | PDF • 754.0 KB | ||
| 2020-05-11 07:00 |
03_BOTHE_AGO_2020-06-10_Information droits actionnaires_FR.pdf
|
French | PDF • 421.5 KB | ||
| 2020-05-11 07:00 |
11_BOTHE_Rapport_spécial_art_7_228_continuité_Final.pdf
|
Dutch | PDF • 226.0 KB |
Automate Your Workflow. Get a real-time feed of all BioSenic SA filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BioSenic SA
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BioSenic SA via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-08-16 | Rieger Francois | Board | Sell | 2,500,000 | 25,000.00 EUR |
| 2024-08-06 | Rieger Francois | Board | Sell | 868,653 | 7,186.87 EUR |
| 2024-08-05 | POMI SCHNEITER VERONIQUE | Board | Sell | 534,750 | 4,331.47 EUR |
| 2024-08-02 | POMI SCHNEITER VERONIQUE | Board | Sell | 193,900 | 1,609.37 EUR |
| 2024-08-01 | Rieger Francois | Board | Sell | 1,236,684 | 11,463.87 EUR |
| 2024-08-01 | POMI SCHNEITER VERONIQUE | Board | Sell | 140,003 | 1,246.03 EUR |
| 2024-07-31 | POMI SCHNEITER VERONIQUE | Board | Sell | 503,771 | 4,685.07 EUR |
| 2024-07-30 | POMI SCHNEITER VERONIQUE | Board | Sell | 360,021 | 3,348.20 EUR |
| 2024-07-29 | POMI SCHNEITER VERONIQUE | Board | Sell | 372,893 | 3,430.62 EUR |
| 2024-07-24 | POMI SCHNEITER VERONIQUE | Board | Sell | 2,168,361 | 21,033.10 EUR |
Peer Companies
